BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34021648)

  • 1. Chemical characterisation of Pelargonium sidoides root based on LC-QToF-MS non-target screening strategies.
    Panara A; Aalizadeh R; Thomaidis NS
    Phytochem Anal; 2022 Jan; 33(1):40-56. PubMed ID: 34021648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sources of the herbal medicine Umckaloabo.
    Kolodziej H
    Phytomedicine; 2007; 14 Suppl 6():9-17. PubMed ID: 17188477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-proliferative properties of commercial Pelargonium sidoides tincture, with cell-cycle G0/G1 arrest and apoptosis in Jurkat leukaemia cells.
    Pereira A; Bester M; Soundy P; Apostolides Z
    Pharm Biol; 2016 Sep; 54(9):1831-40. PubMed ID: 26794080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproduction of the Medicinal Plant Pelargonium sidoides via Somatic Embryogenesis.
    Duchow S; Blaschek W; Classen B
    Planta Med; 2015 Aug; 81(12-13):1169-74. PubMed ID: 26287694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arabinogalactan-proteins stimulate somatic embryogenesis and plant propagation of Pelargonium sidoides.
    Duchow S; Dahlke RI; Geske T; Blaschek W; Classen B
    Carbohydr Polym; 2016 Nov; 152():149-155. PubMed ID: 27516259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic alterations for increased coumarin production lead to metabolic changes in the medicinally important Pelargonium sidoides DC (Geraniaceae).
    Colling J; Groenewald JH; Makunga NP
    Metab Eng; 2010 Nov; 12(6):561-72. PubMed ID: 20797445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservation strategy for Pelargonium sidoides DC: phenolic profile and pharmacological activity of acclimatized plants derived from tissue culture.
    Moyo M; Aremu AO; Gruz J; Subrtová M; Szüčová L; Doležal K; Van Staden J
    J Ethnopharmacol; 2013 Sep; 149(2):557-61. PubMed ID: 23892203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of an aqueous Pelargonium sidoides extract against herpesvirus.
    Schnitzler P; Schneider S; Stintzing FC; Carle R; Reichling J
    Phytomedicine; 2008 Dec; 15(12):1108-16. PubMed ID: 18691858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzopyranones and their sulfate esters from Pelargonium sidoides.
    Hauer H; Germer S; Elsässer J; Ritter T
    Planta Med; 2010 Mar; 76(4):350-2. PubMed ID: 19809972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel kinase platform for the validation of the anti-tubercular activities of Pelargonium sidoides (Geraniaceae).
    Lukman V; Odeyemi SW; Roth RL; Mbabala L; Tshililo N; Vlok NM; Dewar MJB; Kenyon CP
    BMC Biotechnol; 2020 Sep; 20(1):50. PubMed ID: 32993619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the anti-proliferative activity of Pelargonium sidoides DC with in silico target identification and network pharmacology.
    Pereira ASP; Bester MJ; Apostolides Z
    Mol Divers; 2017 Nov; 21(4):809-820. PubMed ID: 28924942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelargonium sidoides extract for treating acute respiratory tract infections.
    Timmer A; Günther J; Motschall E; Rücker G; Antes G; Kern WV
    Cochrane Database Syst Rev; 2013 Oct; (10):CD006323. PubMed ID: 24146345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Pelargonium sidoides in pediatric patients diagnosed with uncomplicated upper respiratory tract infection: a single-blind, randomized, placebo-controlled study.
    Gökçe Ş; Dörtkardeşler BE; Yurtseven A; Kurugöl Z
    Eur J Pediatr; 2021 Sep; 180(9):3019-3028. PubMed ID: 34304301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antifungal and Cryptococcus neoformans virulence attenuating activity of Pelargonium sidoides extracts.
    Samie S; Trollope KM; Joubert LM; Makunga NP; Volschenk H
    J Ethnopharmacol; 2019 May; 235():122-132. PubMed ID: 30738119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical composition and biological investigation of Pelargonium endlicherianum root extracts.
    Şeker Karatoprak G; Göger F; Yerer MB; Koşar M
    Pharm Biol; 2017 Dec; 55(1):1608-1618. PubMed ID: 28407721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicinal properties and conservation of Pelargonium sidoides DC.
    Moyo M; Van Staden J
    J Ethnopharmacol; 2014 Mar; 152(2):243-55. PubMed ID: 24463034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the Pelargonium sidoides root extract EPs® 7630 prevent asthma attacks during viral infections of the upper respiratory tract in children?
    Tahan F; Yaman M
    Phytomedicine; 2013 Jan; 20(2):148-50. PubMed ID: 23142309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of
    Iacovelli F; Costanza G; Romeo A; Cosio T; Lanna C; Bagnulo A; Di Maio U; Sbardella A; Gaziano R; Grelli S; Squillaci E; Miani A; Piscitelli P; Bianchi L; Falconi M; Campione E
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of umckalin in commercial tincture and phytopreparations containing Pelargonium sidoides by HPLC: comparison of sample preparation procedures.
    Franco L; de Oliveira BH
    Talanta; 2010 Jun; 81(4-5):1368-72. PubMed ID: 20441909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mass spectroscopic characterisation of oligomeric proanthocyanidins derived from an extract of Pelargonium sidoides roots (EPs 7630) and pharmacological screening in CNS models.
    Schötz K; Nöldner M
    Phytomedicine; 2007; 14 Suppl 6():32-9. PubMed ID: 17218089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.